We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Where Single-Use Fermenters Fit in Biologics Manufacturing

Biopharma molecules represented as orange spheres in a molecular visualization.
Credit: iStock.

Producing biologics through development, clinical studies, and commercialization calls for different fermentation scales and production needs. Single-use fermenters can support smaller-scale development and clinical production, while stainless steel systems remain suited to larger-volume manufacturing.


This whitepaper examines how single-use and stainless steel fermentation can work together across a clinical-to-commercial program, covering their applications, operational differences, and limitations.


Download this whitepaper to explore how:

  • Single-use fermenters can produce proteins, pDNA, enzymes, Fabs, and other products made through microbial fermentation
  • Faster changeovers and elimination of cleaning/sterilization steps reduce downtime and increase facility utilization
  • Companies can transition from single-use to stainless steel systems as production scales from early clinical studies toward commercialization
Download the Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.